Johnson & Johnson hasn't performed that well in the past decade. By contrast, Vertex Pharmaceuticals and Intuitive Surgical have been exceptional.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
If you are looking for AI-related stocks you can buy and hold forever, look no further than this list. The stocks on this list are applying AI, and the application of AI counts.
As I'm sure everyone reading this is aware, artificial intelligence, or AI, has been quite a volatile sector in the recent past. All indicators suggest this will continue in the near to semi-long-term future.
Intuitive Surgical has an impressive international growth opportunity with hospitals. Growth and valuation expansion have combined to fuel investment returns.
Intuitive Surgical's procedure volume in one key category is declining. However, the medical device specialist continues to record excellent financial results.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Double digit growth is back for the maker of da Vinci.
Does Intuitive Surgical, Inc. (ISRG) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here is how Intuitive Surgical, Inc. (ISRG) and biote Corp. (BTMD) have performed compared to their sector so far this year.
Shares of Intuitive Surgical ISRG surged 9.3% last Friday, after the company announced second-quarter results. The share price touched an all-time high of $456.81 and also closed at a record high of $455.01.
Intuitive Surgical's NASDAQ: ISRG stock bucked the broad-market selloff because of its operational quality, performance, outlook, and balance sheet, which has absolutely nothing wrong with it. The B/S highlights for Q2 include a 490 basis point increase in cash and securities and the net cash position.